AI assistant
Sending…
ORAGENICS INC — Director's Dealing 2018
Jun 26, 2018
35380_dirs_2018-06-26_30e48a89-ee77-424e-99a7-edbde2034ba0.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: ORAGENICS INC (OGEN)
CIK: 0001174940
Period of Report: 2018-06-22
Reporting Person: POPE CHARLES L (Director)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2018-06-22 | Common Stock | A | 4000 | $0.00 | Acquired | 28108 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2018-06-22 | Non-Employee Director Option (Right to Buy) | $1.52 | A | 14000 | Acquired | 2028-06-22 | Common Stock (14000) | Direct |
Footnotes
F1: Represents an award of restricted stock in connection with service to the Company as a director pursuant to the 2012 Equity Incentive Plan that vests immediately.
F2: Represents an award of options to purchase shares of the Company's common stock under the Company's 2012 Equity Incentive Plan in connection with service to the Company as a director. The options vest one year from the grant date. The option exercise price is the closing price on the date of the grant, June 22, 2018.
More from ORAGENICS INC
Proxy Solicitation & Information Statement
2026
May 20
Proxy Solicitation & Information Statement
2026
May 20
Regulatory Filings
2026
May 19
Interim / Quarterly Report
2026
May 8
Regulatory Filings
2026
May 7
Regulatory Filings
2026
Apr 13
Regulatory Filings
2026
Mar 23
Regulatory Filings
2026
Mar 19
Regulatory Filings
2026
Jan 22
Regulatory Filings
2026
Jan 22